HPV Research Current Events | HPV Research News
|
|
|
Sort By:
Page Views | Date |
HPV vaccine does not appear to be effective for treating pre-existing HPV infection
For women with human papillomavirus (HPV) infection, use of the HPV-16/18 vaccine will not accelerate reduction of the virus and should not be used to treat the infection, according to a study in the August 15 issue of JAMA. view more (2007-08-15)
Scientists identify common HPV genotypes in northern India, encourage vaccination
Although a wide spectrum of human papillomavirus is seen across the population of India, HPV-16 and HPV-18 are the most common types and a vaccination targeting these types could eliminate 75 percent of the cervical cancers in the region. view more (2009-10-12)
HPV LINKED TO CERVICAL LESIONS
Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study BMJ Volume 325, pp 572 - 576 Infection with humanpapillomavirus (HPV) is linked to an increased... view more... (2002-09-10)
HPV infection common among females in US
Data from a national study suggests that about one in four U.S. females between the ages of 14 and 59 years may have the sexually transmitted infection human papillomarivus (HPV), according to a study in the February 28 issue of JAMA. view more (2007-02-28)
Oestrogen may be associated with virus (HPV) infection implicated in cervical cancer
The female hormone oestrogen may have a role in HPV viral infection, strains of which are implicated in cervical cancer, shows research in Sexually Transmitted Infections. view more (2002-06-17)
Response from Dr Peter Sasieni, senior scientist at Imperial Cancer Research Fund, in response to new research* that shows HPV is present in 99.7% of cervical cancers.
Response from Dr Peter Sasieni, senior scientist at Imperial Cancer Research Fund, in response to new research* that shows HPV is present in 99.7% of cervical cancers. view more (1999-08-25)
'WAIT AND SEE' POLICY' SUGGESTED FOR WOMEN WITH ABNORMAL CERVICAL SMEARS IN PRESENCE of HIGH-RISK HUMAN PAPILLOMAVIRUS (p 1782)
Women with abnormal cervical smears (mild to moderate dyskaryosis) and who are positive for the high-risk form of human papillomavirus (HR-HPV) should not be treated for at least 6 months after cytological screening to see if the virus disappears, suggest authors of a research letter in this week's issue of THE LANCET. If viral clearance occurs,... view more... (2001-11-21)
HPV testing could be future strategy for primary screening for cervical cancer (pp 1866, 1871)
Embargoed 0001 h (London time) 5 December 2003. Authors of a UK study in this week's issue of THE LANCET propose a new approach for cervical cancer screening. Testing for the human papilloma virus (HPV)-the main cause of cervical cancer-could be the primary screening tool, with cytology reserved for women who test positive for HPV. HPV testing... view more... (2003-12-03)
Self-collection of specimens for HPV testing
n this Research letter, Dr. Gina Ogilvie and colleagues investigate the feasibility of self-collection of specimens for HPV testing among women who may not make full use of cytology screening programs (e.g., women who are homeless or who are involved in the sex trade) and are thus at increased risk of cervical cancer. view more (2007-08-28)
Rare head and neck cancer linked to HPV, study finds
An increase in cases of a rare type of head and neck cancer appears to be linked to HPV, or human papillomavirus, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. view more (2009-10-08)
Human Papilloma virus as a predictor of cervical cancer
Two studies published in this week's issue of THE LANCET suggest that the detection of the amount of human papillomavirus (HPV) could help identify women at risk of cervical cancer. Infection with certain types of HPV - which is common among young women - increases the risk of cervical cancer. However, less than 1% of young women positive for... view more... (2000-06-22)
Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening
A study published in the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers. view more (2008-10-31)
Risky Surgery Not Always Necessary to Treat Cervical Disease
Revolutionary advancements in the treatment options for diseases associated with human papillomavirus (HPV) now include nonsurgical options such as chemoprevention and vaccines. A review of these methods is published in the latest issue of the International Journal of Gynecological Cancer. view more (2005-03-23)
Higher risk for cervical cancer seen among women infected with multiple HPV types
The risk for developing the tissue abnormalities, or lesions, that typically precede cervical cancer is much higher for women infected with multiple genotypes of the human papillomavirus (HPV) than previously reported. view more (2006-07-11)
Viruses may play a role in lung cancer development
Papers presented at the 1st European Lung Cancer Conference, jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland highlight emerging evidence that common viruses may contribute to the development of lung cancer. view more (2008-04-25)
UIC study finds girls aware of HPV vaccine's benefits
Contrary to concerns that the human papillomavirus vaccine might promote promiscuity, a national survey of girls and young women found that the majority of respondents did not believe the HPV vaccine protected them against other sexually transmitted infections. view more (2009-10-16)
Cancer-causing virus associated with higher risk of new HIV infection
Infection with anal human papillomavirus (HPV), a virus that can cause anal and cervical cancers, is associated with a higher risk of new HIV infection in previously HIV-negative men who have sex with men (MSM), according to new UCSF research. view more (2009-05-01)
ADDING HPV TESTING TO CERVICAL SCREENING COULD SAVE LIVES AND SAVE MONEY
Adding a test for a virus known to cause cervical cancer to the conventional cervical smear test improves the detection of cervical abnormalities in women over 34 years old. Research published today1 shows that the use of a test for the human papilloma virus (HPV) in addition to the current Pap smear increases the number of high-grade... view more... (1999-09-09)
Cervical cancer - a single vaccine could benefit most women
The risk of developing cervical cancer by women infected with the Human Papillomavirus (HPV) is essentially the same no matter which type of virus is involved, provided it belongs to the group of 15 or so that are currently identified as high risk, a scientist said today. view more (2003-09-20)
HPV testing finds precancerous lesions at a higher rate than conventional pap smears
Human papillomavirus (HPV) testing was more sensitive than traditional Pap smears at detecting precancerous lesions of the cervix. view more (2006-06-07)
|
|
|
|
Sort By:
Page Views | Date |
|
